Cite
HARVARD Citation
Ochoa-Azze, R. et al. (2022). Safety and immunogenicity of the FINLAY-FR-1A vaccine in COVID-19 convalescent participants: an open-label phase 2a and double-blind, randomised, placebo-controlled, phase 2b, seamless, clinical trial. Lancet. 10 (8), pp. 785-795. [Online].